Negev Capital Announces Final Close of $30M+ for Fund One, Set to Back Psychedelic Drug Development Startups
Toronto, Ontario--(Newsfile Corp. - January 17, 2022) - Negev Capital, a psychedelic medical intervention investment fund, today announced the final close of its investment vehicle, "Fund One" at US$30 million of fully contributed capital, thanks to the strong support from Negev's existing limited partner base and new...
2022-01-17 8:44 AM EST
Negev Capital Invests in Production and Distribution of Artisanal Functional Mushrooms
Toronto, Ontario--(Newsfile Corp. - October 12, 2021) - Negev Capital has invested an undisclosed amount into a life sciences company focused on the production and distribution of artisanal functional mushrooms, Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"). Negev Capital is a psychedelic medical intervention investment fund with assets of USD$25+ million. Psyched is a Canadian-based supplements company focused on the distribution and development of...
2021-10-12 7:30 AM EDT
Negev Capital "Doubled Down" on Its Sizable Investment in Small Pharma Inc.
Toronto, Ontario--(Newsfile Corp. - September 21, 2021) - Negev Capital, a psychedelic medical intervention investment fund, has recently "doubled down" on its sizable investment in Small Pharma Inc (TSXV: DMT), a neuropharmaceutical company specialised in IP-led development of novel treatments for mental health conditions, with a focus on depression.Negev Capital has a broader strategic relationship with Small Pharma, and this latest investment increases the cumulative investment to (USD)$1...
2021-09-21 7:00 AM EDT